Peptide record

TPDB77639

LinNMe Blood-Brain Barrier modified_plain modified
30 amino acids
Basic Information
TPDB77639
LinNMe
Blood-Brain Barrier
Delivery and barrier-penetrating peptides
Peptipedia
modified_plain
Yes
A 30-aa modified blood-brain barrier peptide sequence curated from Peptipedia, without an available 3D structural model.
C-terminal: Amidation
Sequence
YaGF-(Nω-methylguanidino)A-NH2
Physicochemical Analysis
C104H149N29O33S1
RCQKPSWV
N
2365.56
5.05
2
2
10
-2
2.08
-0.287
49.00
Mammalian: 2.8 hour Yeast: 10 min E.coli: 2 min
2980
125.97
7
Residue Composition
number
3
A
0
R
4
N
1
D
0
C
1
E
0
Q
2
G
2
H
2
I
1
L
0
K
1
M
1
F
0
P
0
S
1
T
0
W
2
Y
0
V
Amino Acid Distribution
A: 3 R: 0 N: 4 D: 1 C: 0 E: 1 Q: 0 G: 2 H: 2 I: 2 L: 1 K: 0 M: 1 F: 1 P: 0 S: 0 T: 1 W: 0 Y: 2 V: 0
Chemical Descriptors
30
C104H149N29O33S1
2365.56
5.05
-2
2.08
-0.287
Linear
Similarity
Tyr-(D)Ala-Gly-Phe-(Nω-methylguanidino)Ala-NH2
Evidence Records 5 records
Evidence 1 Activity

Activity

Blood-Brain Barrier
-0.02 min-1

Assay & Model

Efflux study ICU
Origin/Source
Brain elemination rate constant

Source & Reference

NA
B3Pdb

Other

synthetic,milkweed bug
Permeability
Direct iodination
Evidence 2 Activity

Activity

Blood-Brain Barrier
14.16%

Assay & Model

Capillary depletion
Origin/Source
% capillary

Source & Reference

NA
B3Pdb

Other

synthetic,milkweed bug
Direct iodination
Evidence 3 Activity

Activity

Blood-Brain Barrier
85.84%

Assay & Model

Capillary depletion
Origin/Source
% parenchyma

Source & Reference

NA
B3Pdb

Other

synthetic,milkweed bug
Direct iodination
Evidence 4 Activity

Activity

Blood-Brain Barrier
0.00017 mL/(g x min)

Assay & Model

Origin/Source
Unidirectional influx rate constant

Source & Reference

NA
B3Pdb

Other

synthetic,milkweed bug
Intravenous
Permeability
Direct iodination
Evidence 5 Activity

Activity

Blood-Brain Barrier
0.02347 ml/g

Assay & Model

Origin/Source
Initial disrobution volume

Source & Reference

NA
B3Pdb

Other

synthetic,milkweed bug
Intravenous
Permeability
Direct iodination
Additional Detail Fields 1 fields
Intravenous